BioNTech SE

BNTXNASDAQHealthcare● Active

$88.08

$-1.51(-1.69%)

Market Cap$22.3B

P/E Ratio—

52W High$124

52W Low$79.52

Avg Volume1.2M

Open$89.51

Beta1.32

Net Income Financials Revenue

BioNTech SE (BNTX) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

BNTX · net income · updated Jun 8, 2026

Core profitability metrics

BNTX · net income · margin · TTM · CAGR

Net income was −$1.09B for FY2025 (fiscal year ending 2025-12-31), down 64.0% year-over-year. Net profit margin was -39.6%. Based on available data, BioNTech SE has been profitable since at least 2020.

FY2025 Net Income−$1.09B▼ -64.0% YoY

Trailing 12M (TTM)−$1.26Btrailing 4 quarters sum

Net Profit Margin-39.6%−$1.09B ÷ $2.76B

YoY Change-64.0%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 8, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2020

▸ FMP /income-statement · Annual · BNTX net income history · BNTX profit margin

Annual net income data

BNTX · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2025Loss−$1.09B▼ 64.0%-39.6%$2.76B

FY2024Loss−$665.3M▼ 171.5%-24.2%$2.75B

FY2023$930.3M▼ 90.1%24.4%$3.82B

FY2022$9.43B▼ 8.3%54.5%$17.31B

FY2021$10.29B▲ +67613.8%54.2%$18.98B

Net income vs peers (Healthcare)

BNTX vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

BioNTech SEYOU

BNTX

−$1.09B-64.0%-39.6%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

BioNTech SE (BNTX) reported net income of −$1.09B for FY2025 (fiscal year ending 2025-12-31), down 64.0% year-over-year. The net profit margin was -39.6% — meaning the company kept $-0.40 of every dollar of revenue as profit.

Based on available data, BioNTech SE has been profitable since at least 2020. Net income reached a peak of $10.29B in FY2021. Data available for 9 fiscal years.

BioNTech SE's net profit margin was -39.6% for FY2025, based on the latest annual results.

Investors sometimes search for "BioNTech SE net worth" — the company's market capitalization is a separate figure from BNTX net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

BNTX net income · 4 questions

BioNTech SE is not currently profitable on an annual basis. The company reported a net loss of $1.09B for FY2025.

is BNTX profitabledoes BNTX make a profitBNTX profitabilityBNTX profitable company

▸ Source: FMP /income-statement · GAAP · BioNTech SE · BioNTech SE SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026